Primary Endpoint
The main outcome measure that a clinical trial is designed to evaluate, the specific result that determines whether the treatment is considered effective.
In Detail
A primary endpoint is the main outcome that a clinical trial is designed to measure and the result upon which the success or failure of the trial is judged. It is defined in the study protocol before the trial begins and must be specified in the trial registration on ClinicalTrials.gov. The choice of primary endpoint is one of the most critical decisions in trial design because it determines the sample size, study duration, and statistical analysis plan. Common primary endpoints include overall survival (time until death), progression-free survival (time until disease worsens), objective response rate (percentage of patients whose tumors shrink), and patient-reported outcomes such as pain scores or quality of life measures. The FDA has specific guidance on acceptable primary endpoints for different disease areas. For cancer, overall survival is considered the gold standard, but the agency increasingly accepts surrogate endpoints like progression-free survival for accelerated approval. A trial typically has only one primary endpoint, though some trials use co-primary endpoints (two endpoints that both must show statistical significance) or composite endpoints (combining multiple outcomes into a single measure). The statistical analysis is powered around the primary endpoint, meaning the trial enrolls enough participants to detect a meaningful difference in this specific outcome with a predetermined level of confidence. Results on the primary endpoint are what regulators, physicians, and patients look to first when evaluating whether a new treatment represents a meaningful advance.
Frequently Asked Questions
What does "Primary Endpoint" mean in clinical trials?
The main outcome measure that a clinical trial is designed to evaluate, the specific result that determines whether the treatment is considered effective.
Why is "primary endpoint" important for patients?
Understanding primary endpoint helps patients and caregivers navigate clinical trial participation with confidence. It is part of the broader clinical research process that ensures treatments are safe and effective before reaching patients.
Related Terms
Secondary Endpoint
Additional outcome measures in a clinical trial that provide supporting evidence about the treatment's effects, safety, or quality-of-life impact.
Statistical Significance
A mathematical determination that the observed results of a clinical trial are unlikely to have occurred by chance, typically defined as a p-value less than 0.05.
Clinical Trial
A research study that tests a medical treatment, drug, device, or intervention in human volunteers to determine whether it is safe and effective.
Phase 3 Trial
A large-scale study that confirms effectiveness, monitors side effects, and compares the new treatment to existing options, the final step before seeking regulatory approval.
this entity is one of the U.S. clinical trials and research registries concepts that recurs across this site. The definition above is the technical answer; the paragraphs below add the practical context for how the concept connects to the the NIH ClinicalTrials.gov registry data behind every per-entity page on the site.
In the the NIH ClinicalTrials.gov registry data, this concept shapes one or more of the fields that drive the per-entity grades and rankings on this site. The methodology page describes which fields feed into which output; this glossary entry documents the underlying term.
Source: ClinicalTrials.gov, 2026.